Related Experiment Video
Updated: May 5, 2026
07:24
A Protocol for the Production of KLRG1 Tetramer
Published on: January 12, 2010
10.0K
KLRG1, Another Opportunity for a Breakthrough in MTCL.
Gaurav Varma1,2, Catherine S Diefenbach1,2
1Division of Hematology and Medical Oncology, Department of Medicine, NYU Grossman School of Medicine, New York, New York.
Summary
New antibody therapies targeting killer cell lectin-like receptor G1 show promise for treating mature T-cell lymphomas. These antibodies may offer improved specificity for cancer cells, potentially reducing toxicity compared to older treatments.
Area of Science:
- Oncology
- Immunology
- Hematology
Background:
- Mature T-cell lymphomas (MTCLs) have poor prognoses.
- Previous monoclonal antibody (mAb) therapies for MTCLs faced challenges with limited efficacy and severe immunocompromise.
- Targeting specific cell surface markers may improve treatment outcomes.
Purpose of the Study:
- To evaluate the potential of anti-killer cell lectin-like receptor G1 (KLRG1) monoclonal antibodies (mAbs) for treating MTCLs.
- To assess if KLRG1 mAbs offer greater selectivity for malignant T cells.
- To determine if KLRG1 mAbs can mitigate toxicity concerns associated with prior MTCL treatments.
Main Methods:
- Development and testing of novel anti-KLRG1 mAbs.
- In vitro and/or in vivo studies to assess antibody binding specificity to malignant T cells.
- Evaluation of the safety profile and potential toxicities of KLRG1 mAbs compared to existing therapies.
Main Results:
- Anti-KLRG1 mAbs demonstrate potential for enhanced selectivity and specificity towards malignant T cells.
- These novel antibodies may circumvent the significant immunocompromise observed with previous therapeutic approaches.
- Preliminary findings suggest a potentially improved toxicity profile.
Conclusions:
- Anti-KLRG1 mAbs represent a promising new therapeutic strategy for mature T-cell lymphomas.
- This approach may overcome limitations of previous treatments, offering better efficacy and safety.
- Further research is warranted to fully elucidate the clinical utility of KLRG1-targeted therapies.
More Related Videos
06:54MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
11.2K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
17.9K
Related Concept Videos
02:34Competition
21.4K
When organisms require the same limited resources within an environment, they may have to compete for them. Competition is a net-negative interaction. Even if two competing individuals or populations do not interact directly, the overall fitness of both competitors is lowered as a result of not having full access to the limited resource.
21.4K
02:35RACE - Rapid Amplification of cDNA Ends
5.9K
Rapid Amplification of cDNA Ends, or RACE, is one of the most effective methods to obtain a full-length cDNA from an mRNA sequence between a known internal region to the unknown sequence at the 5’ or 3’ end. The unknown region is cloned in the cDNA by a gene-specific primer that binds the known end, and a hybrid primer that attaches a predefined anchor sequence to the unknown end of the cDNA. The sequence in between is amplified by PCR with an anchor primer and a gene-specific...
5.9K
01:10Torque
18.5K
Torque is an important quantity for describing the dynamics of a rotating rigid body. We see the application of torque in many ways in the world, such as when pressing the accelerator in a car, which causes the engine to apply additional torque on the drivetrain. Here, we define torque and provide a framework to create an equation to calculate torque for a rigid body with fixed-axis rotation.
Torque can be considered as the rotational counterpart to force. Since forces change the translational...
Torque can be considered as the rotational counterpart to force. Since forces change the translational...
18.5K
01:25Rab Cascades
2.9K
Rab GTPases act in a regulated cascade during membrane fusion, helping the lipid bilayers mix. The Rab family of proteins are active when bound to GTP, and inactive when bound to GDP. Hence, they act as guanine nucleotide-dependent molecular switches. Rab-GTP recognizes and binds to long or short-range tethering proteins to capture the target vesicle. These tethers coordinate with SNAREs on the vesicle and the target membrane to assemble the trans SNARE complex that locks the mixing bilayers.
2.9K
01:21Rolling Resistance
827
When a solid cylinder rolls steadily on a rigid surface, the normal force applied by the surface on the cylinder is perpendicular to the tangent at the contact point. However, since no materials are entirely rigid, the surface's reaction to the cylinder involves a range of normal pressures.
For instance, imagine a hard cylinder rolling on a comparatively soft surface. The cylinder's weight compresses the surface beneath it. As the cylinder moves, the material in front of it slows down due to...
For instance, imagine a hard cylinder rolling on a comparatively soft surface. The cylinder's weight compresses the surface beneath it. As the cylinder moves, the material in front of it slows down due to...
827
01:17Rolling Resistance: Problem Solving
996
Rolling resistance, also known as rolling friction, is the force that resists the motion of a rolling object, such as a wheel, tire, or ball, when it moves over a surface. It is caused by the deformation of the object and the surface in contact with each other, as well as other factors like internal friction, hysteresis, and energy losses within the materials. Rolling resistance opposes the object's motion, requiring additional energy to overcome it and maintain movement. In practical...
996